Black Health
Thiazide-type diuretic Hypertension Edema

Chlorthalidone (Thalitone) and Black patients

Brand names: Thalitone

Last reviewed: Sources checked:

What Chlorthalidone does

Chlorthalidone is a thiazide-type diuretic with a much longer half-life than hydrochlorothiazide — roughly 40–60 hours — giving it smoother 24-hour blood pressure control from a single morning dose. It is the thiazide used in the three trials that established this drug class's mortality benefit: ALLHAT, SHEP, and the MRFIT follow-up.

What the evidence says for Black patients

Chlorthalidone has the strongest outcome evidence of any first-line antihypertensive in Black adults. The ALLHAT trial randomized 15,094 Black participants and found that chlorthalidone matched amlodipine and outperformed lisinopril for stroke and combined cardiovascular events in the Black subgroup (Wright et al., JAMA 2005;293:1595–1608).

Because Black adults are more likely to be 'non-dippers' — meaning blood pressure does not fall at night the way it does in most people — the long half-life of chlorthalidone offers theoretical advantage in maintaining nighttime BP control, though this is mechanistic reasoning rather than outcome data.

ISHIB and the 2017 ACC/AHA guideline both recommend a thiazide-type diuretic as first-line for Black adults with uncomplicated hypertension, with chlorthalidone or indapamide often preferred over HCTZ when outcome evidence is the deciding factor.

Common alternatives

Hydrochlorothiazide (more commonly prescribed, less outcome evidence), indapamide (long-acting, similar metabolic profile), or a calcium-channel blocker like amlodipine (equivalent outcome evidence in ALLHAT).

Side effects

  • Low potassium (more common than with HCTZ)
  • Low sodium
  • Elevated uric acid, gout flares
  • Modest rise in blood glucose
  • Low magnesium
  • Photosensitivity

Factors that affect adherence

Chlorthalidone is less commonly stocked than HCTZ at some pharmacies and may require a call-ahead; this matters for patients with transportation barriers. Generic pricing is comparable to HCTZ. Pair with a potassium-sparing agent (such as an ACE inhibitor, ARB, or amiloride) if hypokalemia is a recurring problem.

Questions to ask your doctor

Bring this list to your next appointment.

  • Why chlorthalidone vs HCTZ for me?
  • How often will we check my potassium and uric acid?
  • If I have a history of gout, can I still take this?
  • Should I take this in the morning or afternoon to avoid nighttime urination?

References

  1. Wright JT Jr, Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293:1595–1608. PMID 15811979.
  2. ALLHAT Officers. Major outcomes in high-risk hypertensive patients. JAMA. 2002;288:2981–2997. PMID 12479763.
  3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Hypertension Guideline. Hypertension. 2018;71:e13–e115.
  4. Hripcsak G, Suchard MA, Shea S, et al. Comparison of chlorthalidone vs hydrochlorothiazide. JAMA Intern Med. 2020;180:542–551.
  5. U.S. Food and Drug Administration. Thalitone (chlorthalidone) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/018589s028lbl.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.